PAVmed (PAVM) Enterprise Value (2015 - 2025)

PAVmed's Enterprise Value history runs 11 years deep, the most recent figure standing at -$13.2 million for Q4 2025.

• On a quarterly basis, Enterprise Value fell 119.28% year-over-year to -$13.2 million in Q4 2025; TTM through Dec 2025 was -$13.2 million, a 119.28% decrease from a year earlier, with the FY2025 full-year figure at -$13.2 million, down 119.28% from the prior year.
• Enterprise Value climbed to -$13.2 million in Q4 2025 per PAVM's latest filing, from -$13.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at $39.9 million in Q3 2024 and bottomed at -$59.5 million in Q4 2021.
• The 5-year median for Enterprise Value is -$14.9 million (2023), against an average of -$17.3 million.
• Across the five-year window, Enterprise Value plunged 415.13% in 2021 and jumped 559.87% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$59.5 million in 2021, then surged by 67.85% to -$19.1 million in 2022, then jumped by 153.19% to $10.2 million in 2023, then slumped by 159.19% to -$6.0 million in 2024, then sank by 119.28% to -$13.2 million in 2025.
• Per Business Quant, the three latest PAVM Enterprise Value figures stand at -$13.2 million (Q4 2025), -$13.4 million (Q3 2025), and -$45.7 million (Q2 2025).